A new therapy “likely to change the face of prostate cancer treatment” for men should be funded for public patients, according to almost 40 cancer consultants. The doctors wrote to HSE CEO ...

He remains symptom-free. The treatment is now approved for more patients. “Patients with metastatic prostate cancer typically receive hormonal therapy as a first treatment,” says Memorial Sloan ...

the radiotracer binds to prostate-specific membrane antigens (PSMA) expressed by the cancer cells. Following the same pathway, a therapy then targets the cancer cells, destroying them with ...

Please provide your email address to receive an email when new articles are posted on . Patients with pathologic complete response after neoadjuvant systemic therapy remained disease-free at 5 ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence ...

Prof. Louise Emmett: "This collaborative Frontiers grant gives us the tools to deeply evaluate optimal combinations with targeted alpha therapy in prostate cancer – aiming for longer better ...

Surgery and radiation therapy for prostate cancer surgery can cause men to become impotent or incontinent. Concerns regarding overtreatment led the U.S. Preventive Services Task Force (USPSTF ...

Representative index cases of various prostate cancer disease states are presented, including suspected high-risk disease, newly diagnosed treatment-naïve metastatic disease, suspected recurrent ...

Prostate cancer remains one of the leading causes of cancer-related deaths among men globally. In the United States, it holds the top spot as the most common cancer diagnosis among men. One of the ...